IP6 (Inositol Hexaphosphate)
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 50% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
800 mg
Serving Size
625
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
Calcium
115 mg
(9% DV)
600 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (98% of products)
Structure/Function (89% of products)
Nutrient (76% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Dairy Free
Sugar Free
Product Information
📋 Directions for Use
Suggested Use: As a dietary supplement, take 800 mg (about 1/3 tsp) once or twice daily, or as directed by a physician.
⚠️ Warnings & Precautions
Always consult a physician before taking any dietary supplement.
Keep out of reach of children.
🧪 Formulation Notes
Free of: sugar, soy, dairy, yeast, gluten, additives
Additional Information
Use an accurate milligram scale.
Contents are sold by weight, not volume. Settling may occur. Store in a dry, cool, dark place.
New
Product Details
UPC / SKU
X000L8CBFT
DSLD Entry Date
2024-04-23
Product Type
Other Combinations
Form
Powder
Brand
BulkSupplements.com
DSLD ID
312055
Data Updated
2026-04-11
Research Evidence
46
Research Sources
55
Avg Quality Score
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
B
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
B
Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
B
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
B
Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
B
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Compare Similar Products
Uridine Monophosphate
Nootropics Depot
100
Calcium Phosphate Powder
Freeda
100
IP6 (Inositol Hexaphosphate)
BulkSupplements.com
100
IP6 (Inositol Hexaphosphate)
BulkSupplements.com
100
IP6 (Inositol Hexaphosphate)
BulkSupplements.com
100